RUSH/SMARCA3 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A, member 3) is capable of sequence-selective DNA binding and ATP-dependent DNA unwinding. In rabbit uterine epithelial cells, RUSH-1α (113 kDa) is the progesterone-dependent splice variant and RUSH-1β (95 kDa) is the oestrogen-dependent splice variant. Rabbit RUSH/SMARCA3 mRNA is primarily regulated at the proximal promoter (−162/+90) via a PRE (progesterone-response element) half-site/overlapping Y-box domain (−38/−26) and two Sp (specificity protein) 3 sites centred at −128 and −58. We investigated hormone regulation by exploring binding of transcription factors to a putative RUSH/SMARCA3 site (−616/−611) and the distal Sp3 (−131/−126) site. In response to progesterone, RUSH-1α binds the RUSH site and the Sp3 site becomes a functional binding site for Egr-1 (early growth-response gene product 1)/Sp (specificity protein)1/3/MAZ (Myc-associated zinc-finger protein)/MZF1 (myeloid zinc finger 1)/c-Rel. TransSignal TF-TF Interaction Arrays, supershift assays and ChIP (chromatin immunoprecipitation) analyses confirmed strong physical interactions between RUSH and Egr-1/c-Rel. Higher-order long-range interactions between RUSH and the Egr-1/c-Rel derivative of the anisotropic flexibility of the intervening DNA sequence were shown with 3C (chromosome conformation capture) assays. Transient transfection assays with mutant constructs showed the co-operative interaction between RUSH and Egr-1 mediates repression by c-Rel. Thus DNA-bound RUSH/SMARCA3 communicates with its own proximal promoter by looping the intervening DNA. Moreover, progesterone-dependent DNA looping is an adjunct to progesterone induction of the RUSH/SMARCA3 gene because the availability of RUSH isoforms and relevant binding partners is progesterone-regulated.
Introduction
All transcription is controlled spatially and temporally by protein-DNA and protein-protein interactions. When genes are direct targets of nuclear receptor signalling, nuclear receptors, a specialized group of ligand-affiliated transcription factors, bind to promoter-proximal and promoter-distal regulatory sites [1] . Nuclear receptors recruit co-regulators, of which some are chromatin-remodelling factors capable of altering the accessibility of the DNA to additional transcription factors, and they modulate the activity of other transcription factors [2] . DNA looping is a dynamic component of transcription. It brings proteins bound at distal DNA sites into molecular contact with proteins bound to the promoter Key words: DNA looping, progesterone receptor, RING-finger, RUSH/SMARCA3/HLTF, secretoglobin. Abbreviations used: 3C, chromosome conformation capture; CASTing, cyclic amplification and selection of targets; ChIP, chromatin immunoprecipitation; DPE, downstream promoter element; Egr-1, early growth-response gene product 1; EMSA, electrophoretic mobility-shift assay; HLTF, helicase-like transcription factor; Inr, initiator element; PAI-1, plasminogen activator inhibitor-1; RING, really interesting new gene; SMARCA3, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A, member 3; Sp, specificity protein; UTR, untranslated region. 1 Owing to exceptional unforeseen circumstances, this speaker was unable to give this presentation at the meeting. This paper is included in the interest of completeness of the session. 2 To whom correspondence should be addressed (email Beverly.Chilton@ttuhsc.edu).
regardless of the intervening distance, i.e. loops range in size from 50 to several thousand base pairs. Protein participants function as molecular ties that maintain the loops and mediate transcription [3] . Molecular complexity clearly favours the evolution of a transcription process in which the DNAbinding location of a factor does not limit its participation in the event. Pre-mRNA processing, i.e. capping, splicing and cleavage/polyadenylation, is integrated with transcription. Unlike promoter activity, which regulates the amount of transcription product, alternative splicing changes the structure of the product [4] . Ultimately, alternative splicing is a powerful mechanism for macromolecular complexity because splice variants can display different signalling activities, enzymatic properties and subcellular locations. Bioinformatic analyses of existing databases and gene chip analyses support the idea that transcription and alternative splicing are coupled [5] . Our own efforts to understand transcriptional regulation of the RUSH gene have been rewarded with a unique combinatorial perspective on the interrelationship of all of these processes. The present paper contains an overview of our most recent advances in defining a functional link between steroid-dependent alternative splicing of the RUSH gene and isoform-specific autoregulation of its progesteroneresponsive promoter via DNA looping. Six stacks were generated, one for each position, when sequences were inputted to http://weblogo.berkeley.edu. The overall height of each stack indicates the sequence conservation, i.e. nucleotides in positions 2 and 4 are absolutely conserved. The height of the symbols in the stack indicates the relative frequency of each nucleotide, i.e. at position 5, the choices are A, T or G. C was omitted from the logo because its frequency in this position was less than 10 %, i.e. less than expected (25 %) for a random base.
RUSH/SMARCA3/HLTF: the name game
The RUSH [6] symbol recognizes two alternatively spliced transcription factors: a full-length progesterone-dependent α isoform, and a truncated oestrogen-dependent β isoform. Resultant proteins have the same DNA-binding domains, nuclear localization signals, and RING (really interesting new gene) finger motifs. However, RUSH-1α has seven conserved DNA-dependent ATPase domains in contrast with RUSH-1β, which is truncated after the first four. The RUSH acronym encompasses the majority of relevant information in the gene name: R (regions of homology with yeast Rad proteins, RING finger motif, cloned in rabbits); U (expressed in uterus, binds to uteroglobin promoter); S (SWI/SNF-related proteins) and H [cloned in humans as HLTF (helicase-like transcription factor)-1 and HIP116, binds to HIV promoter, helicase-like].
RUSH-1α is 91% identical with the human orthologue that was cloned independently in HeLa cells by three different groups and named HIP116 [7] , human HLTF [8] and ZBU1 [9] . The Human Gene Nomenclature Committee (HGNC) endorsed SMARCA3 (SWI/SNF-related matrixassociated actin-dependent regulator of chromatin subfamily A, member 3) as the gene name in 1998. The A designation was added to the SMARC acronym to highlight the subfamily of SNF2, helicase domains. The number 3 was appended because the number of family members, which is now six, had increased to three. In November 2006, SMARCA3 was officially renamed HLTF (Entrez Gene ID6595) by the HGNC. The P113 symbol for the mouse orthologue [10] was changed to Hltf in the Mouse Genome Database in December of the same year. HLTF has been generally adopted as the official symbol for all known (human, mouse, chimp, frog, zebrafish, dog, and cow) orthologues. The Swiss-Prot record (Q95216) for the rabbit orthologue currently uses HLTF as the provisional symbol for this gene (GeneID: 100 009 232). The RefSeq and Entrez Gene databases maintain connections between orthologous genes by adding alternative symbols as aliases on the records. Using this convention, RUSH remains an alias, just like it was when SMARCA3 was the designated gene name. Throughout this manuscript, we use HLTF and RUSH to distinguish the human and rabbit orthologues respectively.
HLTF binds to the B-box of the PAI-1 (plasminogen activator inhibitor-1) gene [8, 11] , which was renamed SERPINE1 by HGNC. HLTF binds the SPH repeats of the SV40 (simian virus 40) enhancer and the HIV promoter [7] , and the E-box of the MLC1/3 (myosin light chain 1/3) enhancer [9] . HLTF also activates transcription of the β-globin gene via a cis-element in the locus control region [12] . The RUSH-binding site (−126/−121) in the uteroglobin (SCGB1A1) gene, the founding member of the secretoglobin (SCGB) gene family [13] , was identified ( Figure 1 ) by CASTing (cyclic amplification and selection of targets), and authenticated by EMSAs (electrophoretic mobility-shift assays) and ChIP (chromatin immunoprecipitation) assays [14] . Site-directed mutagenesis and transient transfection assays with a rabbit uterine epithelial cell (HRE-H9) line showed that RUSH-1α mediates the ability of prolactin to augment progesterone-dependent transcriptional activation of the SCGB1A1 gene [14] . This paradox of regulation in which a ubiquitous highly conserved transcription factor binds degenerate target sequences was resolved, in part, by the characterization of a bona fide RUSH site (−616/−611) in the 5 -UTR (untranslated gene) of the RUSH gene [15] .
Alternative splicing
The HLTF gene comprises 26 exons [16] . Retention of intron 25 in the 3 -UTR results in the expression of two mRNAs (4.5 and 5.4 kb) that encode the same protein. This outcome is the norm since two or three transcripts are generated from most human genes. Additionally, two different proteins, a fulllength protein (HLTFMet1) and an N-terminally truncated variant (HLTFMet123), result from the use of alternative translation start sites. RUSH is the only HLTF orthologue that is regulated by steroid-dependent alternative splicing [6] . The oestrous state of the endometrium favours the retention of intron 21. In this rare (<5 %) alternative splicing event, a 57 bp fragment with a premature stop codon remains in the mature mRNA to encode RUSH-1β. This truncated protein (836 amino acids) is identical with full-length RUSH-1α through the zinc-finger motif and for 33 amino acids thereafter. Then, because of the retention event, the protein extends for five unique amino acids and stops. The full-length RUSH-1α (1005 amino acids) isoform is expressed in the endometrium during pregnancy or when oestrous animals are treated with progesterone.
RUSH regulation
The first step toward understanding the potential involvement of steroids in co-ordinating transcription with alternative splicing of the RUSH gene required systematic interrogation of the promoter [15] . Truncation analysis of 2057 bp of genomic sequence identified a minimal 252 bp region (−162/+90) with strong basal promoter activity in transient transfection assays. The transcription start site mapped to a consensus Inr (initiator element) in a TATAless region with a DPE (downstream promoter element) (+29). The Inr-DPE combination is conserved in the putative core promoter (−35/+35) of HLTF, suggesting that transcription initiation is similarly conserved. Two GC-rich sites centred at −128 and −58 that are also conserved in the putative promoter of HLTF and a RUSHbinding site (−616/−611) that is unique to the rabbit 5 -UTR repress basal transcription. Analysis of the proximal promoter showed that the −162/+90 region was required for progesterone-responsiveness in transient transfection assays. Mutation/deletion analysis revealed a progesterone receptor half-site mediated induction by progesterone. An overlapping Y-box (in the reverse ATTGG orientation) repressed basal transcription and progesterone-induced transcriptional activation in the presence of the GC-rich sites.
The RUSH site
MatInspector Professional (Genomatix) analysis [17] of the RUSH site identified potential transcription factor-binding sites for FAST-1 on the positive strand, and IRF-3 (interferon regulatory factor-3), SRF (serum-response factor), Elk-1 [ETS (E twenty-six)-like kinase 1] and c-Myb on the negative strand with matrix similarity values 0.80. However, ChIP and supershift EMSA were used to show that the RUSH site is a solo-binding site for RUSH [18] . Isoform-specific binding is dictated by the hormonal milieu. RUSH-1β binds during basal transcription (oestrous) and RUSH-1α binds when the gene is transcriptionally activated by progesterone [18] .
The distal GC-rich site (−131/−126)
GC-rich sites centred at −128 and −58 were authenticated previously as Sp (specificity protein) 1-binding sites [15] . Quantification of supershift EMSA showed that specific binding of Sp3 was 15-17-fold greater than that of Sp1 at each site [18] . MatInspector Professional (Genomatix) analysis [17] of the distal Sp1(A) site (−131/−126) identified putative Egr-1 (early growth-response gene product 1)/Sp/MAZ (Myc-associated zinc-finger protein)/MZF1 (myeloid zinc finger 1) sites on the positive strand, overlapping a putative c-Rel site on the negative strand with matrix similarity values 0.91. The binding of all candidates was confirmed with supershift EMSA [18] . Moreover, the availability of factors that bind to this site was dictated by the hormonal milieu. TransSignal TF-TF Interaction Arrays, supershift assays and ChIP analysis confirmed strong physical interactions between RUSH and Egr-1/c-Rel, but not Sp1. This contrasts with the physical (immunoprecipitation) interaction between HLTF and Sp1/3 in the regulation of basal transcription of the PAI-1 gene [11] . 3C (chromosome conformation capture) assays confirmed the higher-order long-range interactions between RUSH and the Egr-1/c-Rel derivative of the anisotropic flexibility of the intervening DNA sequence. GST (glutathione transferase) pull-downs confirmed the RING finger as the protein-binding domain and showed that the RUSH isoforms share equivalent potential for protein interactions. This warrants further investigation as we have shown previously that the RING finger binds a putative splice variant of ATP11B (ATPase class VI, type 11B) in the inner nuclear envelope [19] .
Site-specific/nuclear interactions
A functional corollary of the 3C assays is that RUSH mediates transcription via a connection between the RUSH site and the distal Sp1(A) site in transient transfection assays. Selective mutation of the RUSH/Egr-1/c-Rel sites individually or in combination showed that c-Rel is an effective repressor (P < 0.001) of progesterone-induced transcription in HRE-H9 cells [18] . Mutation of either the RUSH site or the Egr-1 site had a negligible effect (P > 0.05) on the repressive action of c-Rel. In contrast, co-operation between RUSH and Egr-1 was confirmed when the c-Rel site was mutated.
Functional promoter analyses showed that the induction of RUSH by progesterone is a primary transcriptional response [15] . A rapid response to PRL was confirmed when the intracellular distribution of native RUSH and its putative binding partners was examined using immunofluorescence. HRE-H9 cells were treated with R5020 with or without prolactin to maximize RUSH expression/phosphorylation [20] . Both cRel and RUSH were found in the cytoplasm and nucleus of HRE-H9 cells treated with R5020 + prolactin. Nuclear colocalization of RUSH/c-Rel occurred after a 5 min treatment with prolactin, during which time Egr-1 remained in the cytoplasm. However, after a 15 min treatment, there was detectable co-localization of RUSH/Egr-1 in the nucleus.
Conclusions
Progesterone-induced transcription is fine-tuned, in part, by isoform-specific autoregulation, in which newly synthesized RUSH-1α binds DNA in a sequence selective manner and This working model emphasizes isoform-specific autoregulation in which RUSH-1β binds the RUSH site during oestrous (basal transcription). When the gene is transcriptionally activated by progesterone, the β isoform is replaced by newly synthesized RUSH-1α. The α isoform interacts physically with liganded Egr-1 in the proximal promoter via a DNA-looping mechanism to mediate repression by c-Rel. Progesterone regulates the availability of all of the transcription factors and therefore the process of DNA-loop formation. MAZ, Myc-associated zinc-finger protein; MZF1, myeloid zinc finger 1; NF-Y, nuclear factor Y; POL II, RNA polymerase II; PR, progesterone receptor.
interacts physically with ligand-bound Egr-1 and c-Rel in the proximal promoter as a direct result of chromatin loop formation (Figure 2) . Conversely, in the absence of progesterone induction, the oestrogen-dependent splice variant, RUSH-1β, replaces RUSH-1α binding, and the Egr-1-and c-Rel-binding partners are unavailable (not expressed). RUSH involvement in self-regulation extends our understanding of RUSH function, and adds a new level of complexity as autoregulation entails both RUSH-DNA and RUSH-protein interactions.
